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Introduction
The leading cause of infectious disease death in the United 
States is community-acquired pneumonia (CAP) [1]. Therefore, 
understanding the severity of a specific pneumonia case is 
necessary to best direct life-saving treatment. Several indices 
have been created to categorize pneumonia cases by their severity 
in an ordinal manner. Validation of these severity indices have 
been conducted previously by assessing their discriminatory 
ability to measure the risk of death in a given population [2]. 
However, limited data exists that compares multiple severity 
indices as tests for mortality prediction. Previous validations 
could be the result of confounders for mortality related to the 
severity measurements within a given index. 
The primary objective of this study is to conduct assessments 
of four of the most commonly used pneumonia severity indices 
to evaluate their use as mortality predictors at different time 
points. The secondary objective of this study is to determine, 
which of the four tests is best for making mortality predictions 
in a clinical setting before treatment is delivered.
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Abstract
Background: The leading cause of infectious disease death in the United States is community-
acquired pneumonia (CAP). Several pneumonia severity indices exist and are widely used as tools 
to assist physicians regarding site of care based on risk of death. However, limited data exists that 
discerns which of the most commonly used severity scores is the best predictor of mortality across 
multiple time points. The objective of this study is to determine the best mortality predictor at different 
time points between four of the most commonly used pneumonia severity scores.
Methods: This was a secondary analysis of a prospective, multicenter, population-based, 
observational study of patients hospitalized with CAP in the city of Louisville, KY. The severity 
indices used were the American Thoracic Society (ATS) criteria, the Pneumonia Severity Index (PSI), 
the British Thoracic Society criteria (CURB-65), Quick Sepsis-Related Organ Failure Assessment 
(QSOFA), and direct ICU admission to represent physician discretion. The accuracy, kappa statistic, 
sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 
calculated for the ability to predict in-hospital, 30-day, 6-month, and 1-year mortality. 95% confidence 
intervals for each variable were generated by bootstrapping with random sampling and resampling of 
the subjects 1000 times. In addition, the area under the curve (AUC) was calculated for each severity 
score and mortality time point.
Results: There were 6013 eligible patients included in this analysis with data collected between the 
years 2014 and 2016. At each time point, the QSOFA had the highest sensitivity and NPV, while the 
PSI had the highest specificity and PPV. QSOFA had the highest accuracy for in-hospital mortality, 
30-day mortality, and 6-month mortality, and the CURB-65 had highest mortality for 1-year mortality. 
The QSOFA had the highest kappa statistic for in-hospital mortality, the CURB-65 had the highest 
kappa statistic for 30-day mortality, and the PSI had the highest kappa statistic for 6-month and 1-year 
mortality. The AUC was highest for the ATS criteria for in-hospital mortality, and was highest for the 
PSI at the remaining time points.
Conclusions: The results of this study show that QSOFA and the PSI are the most reliable severity 
indices for mortality predictions based on these measures. QSOFA was found, on average, to have 
the highest accuracy, sensitivity, and NPV. Additionally, PSI was found, on average, to have the 
highest kappa statistic, specificity, and PPV.  The AUC, on average, was best with PSI as the predictor. 
QSOFA is most capable of making true negative predictions and the PSI is the most capable of 
making true positive predictions across the four time points.
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Methods
Study design 
This was a secondary analysis of a prospective, multicenter, 
population-based, observational study of patients hospitalized 
with CAP in the city of Louisville, KY from June 1, 2014 to May 
31, 2016 [3].
Subjects
Patients were only eligible for inclusion in this analysis if 
1) they were hospitalized for CAP during the study period, 
2) pneumonia severity could be assessed for each index, and 
3) mortality at each time point was known.
Study Definitions and Measurements
Community-acquired pneumonia: Screenings were 
conducted for the primary analysis participation for all 
hospitalized adult patients at participating hospitals. Individuals 
were asked to participate in the study if they met the following 
3 criteria: (1) presence of a new pulmonary infiltrate on chest 
radiograph and/or chest computed tomography scan at the 
time of hospitalization, defined by a board-certified radiologist’s 
reading; (2) at least 1 of the following: (a) new cough or increased 
cough or sputum production, (b) fever >37.8°C (100.0°F) or 
hypothermia <35.6°C (96.0°F), (c) changes in leukocyte count 
(leukocytosis: >11000 cells/μL; left shift: >10% band forms/
mL; or leukopenia: <4000 cells/μL); and (3) no alternative 
diagnosis at the time of hospital discharge that justified the 
presence of criteria 1 and 2. 
American Thoracic Society (ATS) Guidelines
List of major and minor criteria for ICU admission intended 
primarily for use by emergency medicine physicians, 
hospitalists, and primary care practitioners in response to 
confusion regarding differences between guidelines for the ATS 
and the Infectious Diseases Society of America [4].
Pneumonia Severity Index (PSI)
A clinical prediction rule that considers patient demographics, 
comorbidities, physical examination findings, vital signs, and 
essential laboratory findings to categorize pneumonia severity 
into five risk classes, with categories IV and V having the highest 
probability of mortality [5].
British Thoracic Society criteria (CURB-65) 
Severity assessment tool that identifies severe CAP and high 
risk mortality in the presence of two or more of the following 
features: mental confusion, respiratory rate > 30/min, diastolic 
blood pressure < 60 mmHg, and blood urea > 7 mmol/l [6].
Quick Sepsis-Related Organ Failure Assessment 
(QSOFA)
Identifies patients with a suspected infection at high risk for 
in-hospital mortality outside of the ICU, based on the following 
criteria: Respiratory rate ≥ 22/min, mental confusion, and 
systolic blood pressure < 100 mm Hg [7].
Definition of Pneumonia Severity
Pneumonia severity was then assessed using 4 severity indices: 
American Thoracic Society (ATS) criteria [3], the Pneumonia 
Severity Index (PSI) [4], the British Thoracic Society criteria 
(CURB-65) [5], Quick Sepsis-Related Organ Failure Assessment 
(QSOFA) [6], and direct ICU admission to represent physician 
discretion. The measurements associated with each index can 
be found in Table 1.
Severity for the ATS criteria was defined as the presence one 
major criteria and/or three minor criteria as defined in the 
guidelines [3]. Severity for the PSI was defined as risk class IV 
or V. Severity for the CURB-65 was defined as a score of 4 or 5. 
Severity for the QSOFA was defined as a score of 3.
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Table 1 Measurements required for each severity index. 
 ATS PSI CURB-65 QSOFA 
Age  x x  
Altered Mental Status x x x x 
Arterial pH  x   
Blood Pressure x x x x 
Body Temperature x x   
BUN x x x  
Cerebrovascular disease  x   
Congestive Heart Failure  x   
Glucose  x   
Heart Rate  x   
Hematocrit  x   
Leukopenia x    
Liver Disease  x   
Mechanical Ventilation x    
Multilobar Infiltrate x    
Neoplastic Disease  x   
Nursing Home  x   
Oxygen Saturation  x   
PaO2/FiO2 x    
Pleural Effusion  x   
Renal Disease  x   
Respiratory Rate x x x x 
Septic Shock x    
Sex  x   
Sodium  x   
Thrombocytopenia x    
Vasopressors x    
 
Table 2 Patient characteristics
 
Variable Value 
Total n 6013 
Demographics 
Age, mean (standard deviation) 67 (17) 
Male sex, frequency (%) 2762 (46) 
African American race, frequency (%) 1205 (20) 
Severity, frequency (%) 
Direct ICU admission 1060 (18) 
One major and/or three minor ATS criteria 2415 (40) 
PSI risk class IV or V 3711 (62) 
Curb-65 score 4 or 5 975 (16) 
QSOFA score 3 475 (8) 
Mortality, frequency (%) 
In-hospital mortality 426 (7) 
30-day mortality 835 (14) 
6-month mortality 1521 (25) 
1-year mortality 1943 (32) 
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Human Subjects Protection
The study was approved by the Institutional Review Board 
(IRB) at the University of Louisville Human Subjects Research 
Protection Program Office (IRB number 11.0613) and by the 
research offices at each participating hospital. The study was 
exempt from informed consent.
Statistical Analysis
Descriptive statistics were performed. For each severity index, 
severity as defined was used to determine accuracy, the kappa 
statistic, sensitivity, specificity, positive predictive value (PPV), 
and negative predictive value (NPV) for the ability to predict 
in-hospital, 30-day, 6-month, and 1-year mortality. To obtain 
95% confidence intervals for each variable, bootstrapping with 
random sampling and resampling of the subjects 1000 times 
was performed.  In addition, the area under the curve (AUC) was 
calculated for each severity score using the severity as defined 
and each mortality time point.
Results
There were 6013 patients eligible for this analysis. Patient 
characteristics, including the number of patients who met 
severity as defined, and mortality, are shown in Table 2. For in-
hospital mortality, the accuracy (0.888), kappa statistic (0.190), 
sensitivity (0.238), and NPV (0.935) were highest for QSOFA, 
while specificity (0.989) and positive predictive value (0.941) 
were highest for the PSI. For 30-day mortality, the accuracy 
(0.840), sensitivity (0.274), and NPV (0.943) were highest for 
QSOFA, while specificity (0.975) and positive predictive value 
(0.932) were highest for the PSI and the kappa statistic (0.237) 
was highest for CURB-65. For 6-month mortality, the accuracy 
(0.747), sensitivity (0.501), and NPV (0.947) were highest for 
QSOFA, while the kappa statistic (0.246), specificity (0.926) and 
positive predictive value (0.888) were highest for the PSI. For 
1-year mortality, the sensitivity (0.577) and NPV (0.951) were 
highest for QSOFA, while the kappa statistic (0.299), specificity 
(0.888) and positive predictive value (0.868) were highest for 
the PSI and the accuracy (0.700) was highest for CURB-65. 
Across the 4 time points, QSOFA was found to most frequently 
have the highest accuracy (75%), sensitivity (100%), and NPV 
(100%); PSI was found to most frequently have the highest 
kappa statistic (50%), specificity (100%), and PPV (100%). The 
AUC yielded by severity scores for in-hospital mortality ranged 
from 0.600 to 0.693; at one year ranged from 0.546 to 0.685. 
The ATS yielded the highest AUC for in-hospital mortality, and 
the PSI yielded the highest AUC for mortality at all other time 
points. All calculated values can be found in Tables 3-7 and 
Figures 1-5. 
Discussion
This study indicates that QSOFA and the PSI are the most 
reliable severity indices for mortality predictions over the short 
and long-term. QSOFA is the most reliable severity index for 
accuracy, sensitivity, and NPV whereas the PSI is the most 
reliable severity index for the kappa statistic, specificity, and 
PPV. QSOFA is most capable of making true negative predictions 
and PSI is most capable of making true positive predictions. 
From the AUC values, we can see that the PSI is the most 
consistent, while QSOFA was always the poorest performer in 
predicting outcomes at every time point.
One important clinical implication is that these severity indices 
consistently outperform a physician’s discretion when severity is 
determined. However, these indices are used almost exclusively 
in research settings and not in a clinical setting. This shows a 
need for an index that can predict mortality during the course 
of a patient’s hospital stay to better direct medical interventions 
and improve health outcomes related to pneumonia.
This data supports the study and creation of these indices. 
However, the agreement between severity and mortality is 
poor across all indices at each time point, as evidenced by the 
low Kappa statistics and AUC values. No AUC went above 0.7, 
indicating that alone these severity indexes at a dichotomous 
cut-point do not exhibit strong predictive power for predicting 
mortality. Also, accuracy decreases as the time increases. This 
shows a need for an index that can better predict long-term 
mortality with higher accuracy.
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Table 3 Statistical measures for severity indices with in-hospital mortality as the outcome.
Table 5 Statistical measures for severity indices with 6-month mortality as the outcome.
Table 6 Statistical measures for severity indices with 1-year mortality as the outcome.
Table 7 Area under the curve (AUC) for mortality outcomes with severity indices as the predictor.
Table 4 Statistical measures for severity indices with 30-day mortality as the outcome.
In Hospital 
  ATS PSI CURB65 QSOFA Direct ICU 
Accuracy 0.635 (0.623, 0.646) 0.445 (0.433, 0.458) 0.828 (0.818, 0.837) 0.888 (0.880, 0.895) 0.819 (0.809, 0.829) 
Kappa 0.122 (0.106, 0.139) 0.076 (0.068, 0.085) 0.179 (0.149, 0.211) 0.190 (0.154, 0.226) 0.187 (0.156, 0.216) 
Sensitivity 0.134 (0.121, 0.148) 0.108 (0.099, 0.118) 0.187 (0.161, 0.212) 0.238 (0.199, 0.278) 0.189 (0.167, 0.212) 
Specificity 0.972 (0.966, 0.977) 0.989 (0.985, 0.993) 0.952 (0.946, 0.958) 0.943 (0.938, 0.949) 0.954 (0.949, 0.960) 
PPV 0.761 (0.720, 0.801) 0.941 (0.917, 0.962) 0.427 (0.381, 0.476) 0.265 (0.221, 0.307) 0.469 (0.428, 0.515) 





  ATS PSI CURB65 QSOFA Direct ICU 
Accuracy 0.654 (0.641, 0.666) 0.504 (0.491, 0.517) 0.804 (0.796, 0.815) 0.840 (0.831, 0.849) 0.785 (0.774, 0.796) 
Kappa Stat 0.194 (0.172, 0.215) 0.151 (0.139, 0.164) 0.237 (0.207, 0.269) 0.188 (0.152, 0.220) 0.195 (0.165, 0.229) 
Sensitivity 0.244 (0.227, 0.261) 0.211 (0.199, 0.224) 0.327 (0.296, 0.358) 0.374 (0.328, 0.420) 0.287 (0.262, 0.314) 
Specificity 0.930 (0.921, 0.938) 0.975 (0.969, 0.981) 0.896 (0.888, 0.904) 0.880 (0.871, 0.888) 0.892 (0.883, 0.900) 
PPV 0.699 (0.667, 0.731) 0.932 (0.915, 0.948) 0.378 (0.343, 0.413) 0.211 (0.183, 0.238) 0.363 (0.331, 0.395) 













 ATS PSI CURB65 QSOFA Direct ICU 
Accuracy 0.653 (0.642, 0.665) 0.579 (0.567, 0.592) 0.745 (0.734, 0.757) 0.747 (0.736, 0.758) 0.717 (0.705, 0.729) 
Kappa Stat 0.231 (0.207, 0.256) 0.246 (0.228, 0.263) 0.236 (0.206, 0.265) 0.134 (0.109, 0.160) 0.168 (0.139, 0.198) 
Sensitivity 0.383 (0.363, 0.401) 0.364 (0.349, 0.379) 0.496 (0.465, 0.527) 0.501 (0.455, 0.546) 0.415 (0.385, 0.444) 
Specificity 0.834 (0.823, 0.846) 0.926 (0.915, 0.937) 0.794 (0.784, 0.805) 0.768 (0.757, 0.779) 0.781 (0.771, 0.793) 
PPV 0.608 (0.584, 0.634) 0.888 (0.871, 0.904) 0.318 (0.296, 0.341) 0.156 (0.139, 0.176) 0.289 (0.269, 0.312) 
NPV 0.668 (0.654, 0.682) 0.475 (0.460, 0.489) 0.890 (0.881, 0.899) 0.947 (0.941, 0.954) 0.862 (0.851, 0.872) 
1 Year 
 ATS PSI CURB65 QSOFA Direct ICU 
Accuracy 0.645 (0.633, 0.657) 0.620 (0.609, 0.633) 0.700 (0.690, 0.712) 0.689 (0.679, 0.701) 0.673 (0.661, 0.685) 
Kappa Stat 0.238 (0.213, 0.261) 0.299 (0.281, 0.320) 0.212 (0.189, 0.238) 0.114 (0.093, 0.134) 0.151 (0.125, 0.176) 
Sensitivity 0.461 (0.443, 0.481) 0.454 (0.439, 0.470) 0.572 (0.542, 0.604) 0.577 (0.532, 0.623) 0.489 (0.460, 0.517) 
Specificity 0.769 (0.756, 0.783) 0.888 (0.875, 0.901) 0.725 (0.713, 0.738) 0.699 (0.687, 0.711) 0.712 (0.701, 0.725) 
PPV 0.573 (0.551, 0.595) 0.868 (0.853, 0.883) 0.287 (0.267, 0.308) 0.141 (0.125, 0.156) 0.267 (0.247, 0.286) 
NPV 0.680 (0.666, 0.695) 0.502 (0.487, 0.518) 0.898 (0.888, 0.907) 0.951 (0.944, 0.957) 0.867 (0.856, 0.877) 
 
 
Area Under the Curve (AUC) 
  ATS PSI CURB65 QSOFA Direct ICU 
In-Hospital 0.693 0.674 0.643 0.600 0.658 
30 Day 0.673 0.683 0.626 0.577 0.608 
6 Month 0.638 0.681 0.604 0.552 0.576 
1 Year 0.626 0.685 0.592 0.546 0.567 
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Figure 1 Accuracy of severity models
Figure 3 Sensitivity of severity models
Figure 4 Specificity of severity models
Figure 5 Positive predictive value of severity modelsFigure 2 Kappa statistic of severity models
Figure 6 Negative predictive value of severity models
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